Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Dwayne S. Yamasaki

Dwayne S. Yamasaki, St. Augustine, FL US

Patent application numberDescriptionPublished
20080249458Intraventricular Shunt and Methods of Use Therefor - Methods and apparatus for treating hydrocephalus caused by obstructions in the ventricular system and subarachnoid space of the brain. Embodiments include medical devices and methods for use within the subarachnoid space of the central nervous system to gain access to and treat an obstruction within the ventricles of the brain or a subarachnoid hemorrhage. The obstruction may be aspirated by an aspiration catheter for use in the subarachnoid space. A subarachnoid delivery catheter may then be used to deliver an intraventricular shunt to the opening in the obstruction via the subarachnoid space. A distal end of the delivery catheter is navigated across the obstruction to deploy the intraventricular shunt therein. The intraventricular shunt so positioned reopens the pathway between the ventricles and permits the return of normal cerebrospinal fluid flow there through.10-09-2008
20080249501Methods for Simultaneous Injection and Aspiration of Fluids During a Medical Procedure - Methods for simultaneous injection and aspiration of fluids during a medical procedure are disclosed. Embodiments include methods for operating medical devices within the subarachnoid space of the spinal column to gain access to the ventricles of the brain, as well as the surrounding cranial subarachnoid space. A dual lumen constant volume aspiration catheter is disclosed that injects a volume of injectable fluid to break up an obstruction within the brain or cranial subarachnoid space while simultaneously aspirating a same volume of aspirated fluid from the treatment site. Methods hereof include constant volume re-circulation of cerebral spinal fluid to and from a treatment area within one of the brain and the surrounding cranial subarachnoid space, which may be desirable during a ventriculostomy.10-09-2008
20090248034Method of Diagnosing and Treating Benign Prostatic Hyperplasia - A method of diagnosing and treating a patient having benign prostatic hyperplasia caused by insufficient blood flow to the prostate due to atherosclerosis of a pelvic artery is disclosed. A method of diagnosing the patient's condition includes determining if a stenosis exists within a pelvic vessel. A method of treating the patient's condition may include placing a stent within the stenosed pelvic artery.10-01-2009
20090259296Gate Cannulation Apparatus and Methods - A representation of a prosthesis opening is created and a device having a marker is tracked through the opening while monitoring the relative positions of the opening representation and the marker on a display. In one alternative, a representation is made on a display of the center of the contralateral stump opening and an electromagnetic marker coil that is secured to an endovascular delivery device, and the marker and delivery device are guided into the opening, while monitoring the relative positions of the opening center and the electromagnetic marker coil representations. In another alternative, one or more markers are positioned in the vicinity of the prosthesis opening and a device having a marker is tracked to the one or more markers and through the opening where the device is one of a guidewire and a catheter, while monitoring the relative position of the markers on a display.10-15-2009
20100036471Method of Diagnosing and Treating Lower Urinary Tract Symptoms - A method of diagnosing and treating a patient having lower urinary tract symptoms caused by insufficient blood flow to the urinary bladder, the urethra, a nerve innervating the urinary bladder, or a nerve innervating the urethra due to atherosclerosis of a pelvic artery is disclosed. A method of diagnosing the patient's condition includes determining if a stenosis exists within a pelvic vessel. A method of treating the patient's condition may include placing a stent within the stenosed pelvic artery.02-11-2010
20100129414Bioactive Agent Delivery Using Liposomes in Conjunction With Stent Deployment - Described herein are methods for treating aneurysms, vascular occlusions, and vascular lesions. The methods comprise the use of an implantable medical device which includes a bioactive agent substrate associated with its surface. Liposomes are used to encapsulate the bioactive agent and are delivered either systemically or locally to the bloodstream. A means for liberating the bioactive agents from the liposomes is used once an appropriate location is chosen and the liposomes have distributed themselves through the vasculature. Once liberated, the bioactive agent can be sequestered by the bioactive agent substrate associated with the implantable medical device, and slowly released to impart a therapeutic effect on the surrounding tissues.05-27-2010
20100145222METHOD AND SYSTEM FOR MONITORING A NERVE - A nerve monitoring system facilitates monitoring an integrity of a nerve.06-10-2010

Patent applications by Dwayne S. Yamasaki, St. Augustine, FL US

Dwayne S. Yamasaki, Rohnert Park, CA US

Patent application numberDescriptionPublished
20090259284Resonating Stent or Stent Element - A tubular member adapted for endovascular delivery in a human patient comprises a tubular wire framework and the tubular wire framework forms the core of a signal device. The signal device further includes a coil, which is wrapped around the core to form an inductor, and a capacitor coupled to the inductor to form an inductor capacitor circuit. The signal device can be excited and signals acquired therefrom to determine the position and/or orientation of the signal device and the tubular member. The relative positions and/or orientations of (1) the signal device and/or the tubular member and (2) a device having a signal generating element or a signal generating element being advanced toward the signal device, tubular member or framework can be monitored. Relative positions and/or orientations of a plurality of signal devices in a tubular wire framework also can be determined after the framework is deployed in a vessel and compared to predetermined positions and/or orientations.10-15-2009

Patent applications by Dwayne S. Yamasaki, Rohnert Park, CA US

Dwayne S. Yamasaki, Jacksonville, FL US

Patent application numberDescriptionPublished
20110190596ENDOTRACHEAL TUBE APPARATUS - An apparatus for monitoring EMG signals of a patient's laryngeal muscles includes an endotracheal tube having an exterior surface. Conductive ink electrodes are formed on the exterior surface of the endotracheal tube. The conductive ink electrodes are configured to receive the EMG signals from the laryngeal muscles when the endotracheal tube is placed in a trachea of the patient. At least one conductor is coupled to the conductive ink electrodes and is configured to carry the EMG signals received by the conductive ink electrodes to a processing apparatus.08-04-2011